Duque, Marcelo Dutra; Kreidel, Rogério Nepomuceno; Taqueda, Maria Elena Santos 
; Baby, André Rolim ; Kaneko, Telma Mary ; Velasco, Maria Valéria Robles ; Consiglieri, Vladi Olga
Source: Pharmaceutical Development and Technology. Unidades: EP, FCF
Subjects: COMPRIMIDOS, CELULOSE, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUQUE, Marcelo Dutra et al. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, v. 18, n. 5, p. 1247-1254, 2013Tradução . . Disponível em: https://doi.org/10.3109/10837450.2012.693508. Acesso em: 01 out. 2024.APA
Duque, M. D., Kreidel, R. N., Taqueda, M. E. S., Baby, A. R., Kaneko, T. M., Velasco, M. V. R., & Consiglieri, V. O. (2013). Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, 18( 5), 1247-1254. doi:10.3109/10837450.2012.693508NLM
Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2024 out. 01 ] Available from: https://doi.org/10.3109/10837450.2012.693508Vancouver
Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2024 out. 01 ] Available from: https://doi.org/10.3109/10837450.2012.693508
